Akso Health (AHG) Stock Analysis & Winston Score
Akso Health Group is a small Chinese company that has shifted its business focus several times over the years. It has operated in areas including online lending services, electric vehicles, and more recently health-related services and products. The company primarily targets consumers in China and has struggled to establish a clear, stable core business. Akso Health generates revenue through service fees and product sales, but its financials show serious strain — a gross margin near zero and a deeply negative operating margin signal that the company spends far more than it earns. It is a micro-cap firm with a market value around $100 million, listed on a US exchange but operating mainly in China. The company faces significant risks including regulatory pressure in China, a lack of a durable competitive advantage, and a history of frequent business pivots that make its long-term direction difficult to assess.
Winston Score: 8/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Weak (0/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: $0.93
Market Cap: $794M
Sector: Technology
Industry: Software - Services
Exchange: NASDAQ
